Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

159 results about "Case fatality rate" patented technology

In epidemiology, a case fatality rate (CFR)—or case fatality risk, case fatality ratio or just fatality rate—is the proportion of deaths within a designated population of "cases" (people with a medical condition) over the course of the disease. A CFR is conventionally expressed as a percentage and represents a measure of risk. CFRs are most often used for diseases with discrete, limited time courses, such as outbreaks of acute infections.

Method for monitoring health of domestic animals and system

The invention relates to the field of monitoring of health of livestock and discloses a method for monitoring health of domestic animals and a system. The method comprises the steps: adorning each domestic animal with an electronic tag, arranging a corresponding electronic tag reader in an exercise area of the domestic animals, and arranging an image pick-up device, which is used for acquiring video images of exercise of the domestic animals, in the exercise area of the domestic animals; acquiring an electronic tag identity and individual moving track information corresponding to the corresponding electronic tag identity of each domestic animal by using the video images acquired by the electronic tag reader and the image pick-up device; acquiring a total amount of displacements of each domestic animal once in each interval time T1 by using the individual moving track information; acquiring feed intake condition of each domestic animal; and acquiring water intake condition of each domestic animal. According to the method and the system, moving tracks of domestic animal individuals can be tracked in real time based on electronic tag identities of the domestic animals, locations, amount of exercise, feed intake condition and water intake condition can be monitored, the accurate monitoring on health statuses of the domestic animal individuals is facilitated, and the medication andcase-fatality rate of the domestic animals is reduced.
Owner:成都睿畜电子科技有限公司

Diagnostic reagent kit (enzyme-linked immunosorbent assay (ELISA)) for enterovirus (EV) 71-type antibody (immune globulin M (IgM))

The invention relates to the field of biomedicine, in particular to an enzyme-linked immunization diagnostic reagent kit for detecting an enterovirus (EV) 71-type antibody (immune globulin M (IgM)), and a preparation method and application of the diagnostic reagent kit. The probability of hand-foot-and-mouth disease and severe infection (viral encephalitis, viral cerebrospinal meningitis and pulmonary edema) caused by EV71 type is relatively higher, and case fatality rate is relatively higher and can be 10 to 25 percent. The enzyme-linked immunization diagnostic reagent kit of the EV71-IgM antibody can be used for diagnosing the infection of the EV71 type. According to related documents about the detection of the EV71-IgM, EV71 virus cultures serving as indirect enzyme-linked immuno sorbent assay (ELISA) of envelope antigens has defects in such aspects as specificity, sensitivity and stability, and due to high cultivation cost and low efficiency, a large amount of virus cannot be supplied to the market. In order to overcome the defects, the invention provides the reagent kit which is used for detecting the EV71-IgM in human blood serum, required by clinical examination, simple and convenient to operate and applicable to all medical disease control departments, and the preparation method and the application of the reagent kit. The invention has the technical scheme that: firstly, the human blood serum is added into a micro-pore plate, wherein the IgM antibody is obtained by an anti-mu chain which is pre-enveloped on the micro-pore plate, and other uncombined components are washed and removed; secondly, an enzyme labeling object is added, the EV71-IgM in the obtained IgM can be combined with the specificity of an EV71 recombinant antigen which is labeled by horse radish peroxidase (HRP), and after washing, the HRP can react with substrates which are added subsequently; and finally, the aim of detecting the EV71-IgM antibody is fulfilled.
Owner:BEIJING BEIER BIOENG

Hepatic functional reserve detector capable of removing blood oxygen fluctuation interference

The invention relates to a hepatic functional reserve detector capable of removing blood oxygen fluctuation interference. The hepatic functional reserve detector consists of a photoelectric finger clip sensor, a data memory, a liquid crystal display module, a light source driving circuit, a microprocessor, a signal separating circuit, a signal amplifying circuit, an A/D (analog/digital) conversion circuit, a wireless communication module and a computer, the photoelectric finger clip sensor is respectively connected with the data memory and the liquid crystal display module via the light source driving circuit and the microprocessor, the photoelectric finger clip sensor is connected with the microprocessor via the signal separating circuit, the signal amplifying circuit and the A/D conversion circuit, the microprocessor is connected with the wireless communication module, and the computer is connected with the wireless communication module via Bluetooth. A concentration spectrum of indocyanine green (ICG) pigment used as indicator is separated from a blood oxygen absorbing spectrum, inference of low blood oxygen and blood oxygen fluctuation to pigment concentration measurement is suppressed, a diluted concentration curve of the ICG pigment injected via a vein is accurately measured, the purpose of non-invasively and continuously measuring cardiovascular and hepatic haemodynamics parameters such as pigment blood plasma disappearance rate K, 15-minute detaining rate R15 and the like is achieved, surgery risks can be accurately predicted by means of detecting hepatic functional reserve, a proper therapy mode is selected, and operative mortality and postoperative complications can be effectively reduced.
Owner:JILIN UNIV

Freeze-drying composition of posaconazole prodrug and preparation method and application of freeze-drying composition of posaconazole prodrug

The invention relates to a freeze-drying composition of a posaconazole prodrug and a preparation method and application of the freeze-drying composition of the posaconazole prodrug. The freeze-drying composition has the advantages that the freeze-drying composition is high in water solubility, and safety of the freeze-drying composition is guaranteed due to the fact that cyclodextrins auxiliary materials need not to be added during the preparation of the freeze-drying composition; the freeze-drying composition is suitable for being used for treating various amphotericin-intolerant or refractory adult invasive fungal infections; the freeze-drying composition is used as a preventive drug for high-risk patients, the freeze-drying composition is applicable to patients above 13 years old and with impaired immunity and especially applicable to patients who have graft versus host disease (GVHD) after hematopoietic stem cell transplant, patients with leukemia and patients with long-term leukopenia due to chemotherapy; compared with control drugs such as fluconazole and itraconazole, the freeze-drying composition can effectively prevent invasive aspergillosis and can lower the mortality related to the invasive fungal infections.
Owner:HC SYNTHETIC PHARMA CO LTD

Brain fixed-point sub-hypothermia control device

The invention relates to a brain fixed-point sub-hypothermia control device. The brain fixed-point sub-hypothermia control device comprises an intrusive guide tube, temperature detection elements, a control system, a liquid cooling device and a liquid pushing device, wherein the temperature detection elements (2, 2') are used for respectively monitoring the temperatures of an inlet and an outlet of the intrusive guide tube (1); the temperature detection element (2'') is used for monitoring the temperature of the output cooling liquid of the liquid cooling device (4); and the control system (3) is used for sending a control signal to start the liquid pushing device (5) to push the cooled liquid into the inlet of the intrusive guide tube at a certain speed. With the adoption of the brain fixed-point sub-hypothermia control device, the brain cooling part can be accurately positioned, the cooling process is timely and quick, and the sub-hypothermia state can be accurately and reliably maintained; in addition, acute and serious cerebral edema can be controlled, and conditions are created for promoting recovery of brain function, so that the brain fixed-point sub-hypothermia control device plays an important role in reducing fatality rate and disability rate.
Owner:CAPITAL UNIVERSITY OF MEDICAL SCIENCES

Enterovirus 71 antigen detection test strip (colloidal gold method)

The invention relates to the field of biomedicine, and specifically relates to an enterovirus 71 antigen detection test strip (colloidal gold method) and a preparation method and application thereof. Enterovirus 71 can cause hand-foot-and-mouth disease, which has largegeneration proportion of severe infections (viral encephalitis, meningomyelitis virus and pulmonary edema), and a high death rate reaching 10%-25%. The test strip of the invention is used for rapid diagnosis of EV(enterovirus)71 infection. A virus separation and an RT-PCR (reverse transcription-polymerase chain reaction) are methods first used for EV71 antigen detection, but are not suitable for primary clinic usage due to defects of difficult operation and high costs, etc. The invention overcomes the above insufficiencies and provides a reagent, which is highly demanded in clinic detection, simply operated, suitable for various medical disease control sections, and capable of detecting EV71 antigens in human oropharyngeal swabs, bubble liquid, serum or excrement, and also provides the preparation method and application thereof. A technical scheme is as follows: a specimen is dropped on a sample pad, and the EV71 antigen wherein combines with a gold-labeled EV71 polyclonal antibody in a gold-labeled pad and migrates along a chromatography membrane. A detected line captures colloidal gold particles to form a red line visible to naked eyes, so as to realize detection of the EV71 antigen.
Owner:BEIJING BEIER BIOENG

Optimizing mass spectrogram model for detecting breast cancer characteristic protein and preparation method and application thereof

The invention relates to an optimum mass spectrometry model and a preparation method thereof for detecting the feature protein of breast cancer, belonging to the field of mass spectrometry detection technique. The invention is characterized in that eight up-regulated proteins and three lower-regulated proteins are screened from the blood serum to be used as the feature proteins; any two or more proteins of the eleven proteins are chosen so as to establish a blood serum feature protein mass spectrometry model of identification with two in a group for patients with breast cancer and normal people, and patients with benign breast disease, lymphatic metastasis of breast cancer and remote metastasis of breast cancer according to the mass-charge ratio m/z of each protein peak and the critical peak average value of the protein; the preparation method of the invention provides a foundation for further discovering new breast cancer biological marks. The method of the invention is better than any single detection method adopted currently for the detection of the breast cancer, and provides a non-invasive technique for the early detection and early treatment of the breast cancer, thus providing a new method for reducing the mortality of the breast cancer, improving the cure rate of the breast cancer and screening and examining the breast cancer for high-risk population further.
Owner:许洋

Application of cynaroside to preparation of medicine for treating or preventing hand-foot-and-mouth diseases

The invention discloses application of cynaroside to preparation of a medicine for treating or preventing hand-foot-and-mouth diseases. The hand-foot-and-mouth diseases are caused by an enterovirus type 71, a type 16, type 4, type 5, type 7, type 9 and type 10 of a coxsackie virus group A, a type 2 and type 5 of a coxsackie virus group B or an echovirus. The medicine takes the cynaroside as an active component and is mixed with a pharmaceutically acceptable auxiliary material to prepare any one clinically acceptable dosage form. The application disclosed by the invention provides a new way for treating the hand-foot-and-mouth diseases; the cynaroside can be developed as a new medicine for preventing the hand-foot-and-mouth diseases; the toxic and side effects are small; the lesion of infected cells is inhibited, a dose-dependent effect is realized and the medicine is a broad-spectrum antiviral medicine; virus replication is inhibited, the virus load in host cells is reduced and viruses are promoted to become negative; the case fatality rate is reduced or eliminated and the survival time of illness cases is prolonged; the content of cell factors is reduced and inflammations caused by virus infection is alleviated; a plurality of administration manners are provided and the medicine can be administrated by injection and can also be orally taken.
Owner:JIANGSU KANION PHARMA CO LTD

Infectious disease monitoring and early warning method and device

The invention provides an infectious disease monitoring and early warning method and device. The method comprises the steps: pre-constructing a preset feature set, wherein the preset feature set is determined according to the known infectious disease feature set; when a monitoring and early warning demand exists, obtaining a to-be-monitored electronic medical record first, and extracting the structured data and the post-structured data from the to-be-monitored electronic medical record; determining feature information of the to-be-monitored electronic medical record according to the structureddata and the post-structured data; comparing the feature information with feature information in a preset feature set, and determining the type of the infectious disease in the to-be-monitored electronic medical record; monitoring whether the number of unknown infectious diseases in the infectious disease types reaches a preset threshold value or not in real time; and when the number of unknown infectious diseases in the infectious disease types reaches the preset threshold value, determining that the unknown infectious diseases are to-be-confirmed newly-added infectious diseases so as to realize monitoring and early warning of the unknown infectious diseases. According to the invention, unknown infectious diseases can be discovered in time to reduce the infection probability of people, so that the case fatality rate is reduced.
Owner:北京嘉和海森健康科技有限公司

Traditional Chinese medicine composition and application thereof in prevention and treatment of viral pneumonia

The invention provides a traditional Chinese medicine composition and application thereof in prevention and treatment of viral pneumonia. According to the traditional Chinese medicine composition, 40-130 parts of fructus forsythiae, edible tulip, honeysuckle, scutellaria baicalensis and folium isatidis are used as basic components, and 50-110 parts of a qi-tonifying yin-nourishing component, 20-50parts of a spleen-tonifying circulation-assisting component, 15-50 parts of a phlegm-heat-clearing component, 14-50 parts of a phlegm-eliminating masses-resolving component and 20-50 parts of a lung-promoting, lung-moistening, lung-astringing and asthma-preventing component which accord with incompatibility of traditional Chinese medicines are matched. The traditional Chinese medicine compositionhas the effects of clearing away heat and toxic materials, dispelling wind and promoting exterior syndrome, relieving cough and reducing sputum and tonifying qi and yin, is suitable for treating thenovel coronavirus pneumonia, can effectively relieve symptoms of patients with the novel coronavirus pneumonia and improve prognosis, reduces the diseaseseverity-causing rate and the case fatality rate, and is clear and remarkable in curative effect.
Owner:GUANGZHOU BAIYUSN HUTCHISON WHAMPOA CHINESE MEDICINE

Suckling pig and piggy feed for preventing and treating diarrhoea and preparation method thereof

InactiveCN104351485APromote healthy growthPromotes steady weight gainAnimal feeding stuffGaining weightDisease
The invention discloses a suckling pig and piggy feed for preventing diarrhoea and a preparation method thereof. The feed consists of the raw materials in parts by weight: 200-300 parts of maize flour, 150-200 parts of wheat bran, 100-150 parts of millet flour, 70-90 parts of maize germs, 70-80 parts of whey powder, 50-70 parts of small fish and shrimps, 10-20 parts of lard, 20-30 parts of hedera helix stems, 20-30 parts of musa basjoo stems and leaves, 10-20 parts of cattail stems and leaves, 30-40 parts of malt flour, 7-9 parts of black sesame seeds, 4-6 parts of fennel seeds, 15-20 parts of cannabis meal, 10-15 parts of flax meal, 2-3 parts of ginger, 1-2 parts of sweetberry jointfir , 3-4 parts of spanishneedles herbs, 2-3 parts of plantain herbs, 1-2 parts of agaricus blazei, and 15-20 parts of attractants. The feed disclosed by the invention can well prevent the disease of the diarrhoea for suckling pigs and piggies, treat the suckling pigs and the piggies with the disease of the diarrhoea, can alleviate the state of an illness, and reduce the case fatality rate; at the same time, the feed can promote the suckling pigs and the piggies to grow and gain weight stably, so that the economic benefits of breading the suckling pigs and the piggies are improved.
Owner:ANHUI CHENNUO FEED GREASE PROCESSING

IL-6 and IL-10 bigeminy colloidal gold immunochromatography kit for rapid diagnosis on sepsis

The invention relates to an IL-6 and IL-10 bigeminy colloidal gold immunochromatography kit for rapid diagnosis on sepsis. The kit comprises immunochromatography test paper, a colloidal gold pad and a nitrocellulose membrane, wherein the colloidal gold pad and the nitrocellulose membrane are positioned on the test paper; gold-labeled antibodies on the colloidal gold pad include an IL-6 antibody and an IL-10 antibody; the nitrocellulose membrane comprises a detection line wrapping the IL-6 antibody, a detection line wrapping the IL-10 antibody, and a quality control line wrapping a goat anti mouse antibody from left to right sequentially. The invention further provides a standard colorimetric card for judging detection results, and the standard colorimetric card is used for comparing and distinguishing early-stage sepsis, serious sepsis, gram-negative bacterium infection and gram-positive bacterium infection. The kit provided by the invention has the advantages of stability, simplicity, rapidness, accuracy, no pollution, low expense and the like; on-scale production can be achieved, the early-stage rapid sepsis diagnosis efficiency is improved, the economic burden of patients is reduced, the case fatality rate of sepsis is reduced, and remarkable economic benefits can be made.
Owner:SHANGHAI CHILDRENS MEDICAL CENT AFFILIATED TO SHANGHAI JIAOTONG UNIV SCHOOL OF MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products